BR112013031791A2 - derivados de ftalazinona-pirrolopirimidinacarboxamida - Google Patents

derivados de ftalazinona-pirrolopirimidinacarboxamida

Info

Publication number
BR112013031791A2
BR112013031791A2 BR112013031791A BR112013031791A BR112013031791A2 BR 112013031791 A2 BR112013031791 A2 BR 112013031791A2 BR 112013031791 A BR112013031791 A BR 112013031791A BR 112013031791 A BR112013031791 A BR 112013031791A BR 112013031791 A2 BR112013031791 A2 BR 112013031791A2
Authority
BR
Brazil
Prior art keywords
pyrrolopyrimidinecarboxamide
phthalazinone
derivatives
compounds
formula
Prior art date
Application number
BR112013031791A
Other languages
English (en)
Portuguese (pt)
Inventor
Mann Alexander
Pahl Andreas
Hatzelmann Armin
Hesslinger Christian
Zitt Christof
Flockerzi Dieter
Benediktus Ewald
Christof Holst Hans
Tenor Hermann
Stadlwieser Josef
Hessmann Manuela
Viertelhaus Martin
Hussong Ragna
Hummel Rolf-Peter
Maier Thomas
Stengel Thomas
Kanacher Tobias
Dunkern Torsten
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44764312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112013031791(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of BR112013031791A2 publication Critical patent/BR112013031791A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112013031791A 2011-06-17 2012-06-12 derivados de ftalazinona-pirrolopirimidinacarboxamida BR112013031791A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11170440 2011-06-17
PCT/EP2012/061084 WO2012171900A1 (en) 2011-06-17 2012-06-12 Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives

Publications (1)

Publication Number Publication Date
BR112013031791A2 true BR112013031791A2 (pt) 2017-01-31

Family

ID=44764312

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013031791A BR112013031791A2 (pt) 2011-06-17 2012-06-12 derivados de ftalazinona-pirrolopirimidinacarboxamida

Country Status (22)

Country Link
US (2) US20140112945A1 (https=)
EP (1) EP2721030B1 (https=)
JP (1) JP5980318B2 (https=)
KR (1) KR20140037195A (https=)
CN (1) CN103582644B (https=)
AR (1) AR086915A1 (https=)
AU (1) AU2012269133A1 (https=)
BR (1) BR112013031791A2 (https=)
CA (1) CA2837248A1 (https=)
CL (1) CL2013003556A1 (https=)
CO (1) CO6852074A2 (https=)
CR (1) CR20130656A (https=)
DO (1) DOP2013000298A (https=)
EA (1) EA023713B1 (https=)
EC (1) ECSP13013076A (https=)
ES (1) ES2564882T3 (https=)
MA (1) MA35269B1 (https=)
MX (1) MX2013014888A (https=)
PE (1) PE20140648A1 (https=)
PH (1) PH12013502546A1 (https=)
TN (1) TN2013000439A1 (https=)
WO (1) WO2012171900A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170133497A (ko) 2015-04-09 2017-12-05 갈데르마 소시에떼아노님 인디고 내추럴리스로부터의 추출물 및 그의 제조 방법
JP6803849B2 (ja) * 2015-04-09 2020-12-23 ガルデルマ・ソシエテ・アノニム インジゴナチュラリス又はインジゴ産生植物の抽出物を用いたアトピー性皮膚炎の処置
BR112017021190B1 (pt) 2015-04-09 2021-12-21 Galderma Sa. Uso de uma composição farmacêutica que compreende um extrato de indigo naturalis
EP3280428A1 (en) 2015-04-09 2018-02-14 Galderma S.A. Antibacterial indigo naturalis or indigo-producing plant extract and use thereof
WO2022006470A1 (en) 2020-07-01 2022-01-06 Vanderbilt University Methods of treatment for a kidney disease

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
ATE111364T1 (de) 1989-05-31 1994-09-15 Fisons Plc Medikament und inhalationsvorrichtung dafür.
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69131867T2 (de) 1990-03-23 2000-05-18 Minnesota Mining And Mfg. Co., Saint Paul Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe
ATE114112T1 (de) 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of medicament formulations
BR9806752A (pt) * 1997-01-15 2000-03-14 Byk Gulden Lomberg Chem Fab Ftalazinonas.
SI1070056T1 (en) * 1998-03-14 2004-12-31 Altana Pharma Ag Phthalazinone pde iii/iv inhibitors
JP4672143B2 (ja) 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
US6397838B1 (en) 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method
AU777167B2 (en) 1999-04-23 2004-10-07 Battelle Memorial Institute Directionally controlled EHD aerosol sprayer
IL146034A0 (en) 1999-04-23 2002-07-25 Battelle Memorial Institute High mass transfer electrosprayer
NZ522882A (en) * 2000-06-05 2004-07-30 Altana Pharma Bv Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors
ES2260299T3 (es) 2000-10-09 2006-11-01 3M Innovative Properties Company Formulaciones medicinales en aerosol.
CZ20032491A3 (cs) 2001-02-15 2004-01-14 Altana Pharma Ag Ftalazinonpiperidinové deriváty
EP1385848A2 (en) 2001-04-25 2004-02-04 ALTANA Pharma AG Phtalazinones derivatives useful as pde4/7 inhibitors
BR0313330A (pt) 2002-08-10 2005-06-14 Altana Pharma Ag Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
EP1556369A1 (en) * 2002-08-10 2005-07-27 ALTANA Pharma AG Pyridazinone-derivatives as pde4 inhibitors
WO2004018449A1 (en) 2002-08-10 2004-03-04 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
EP1587512A2 (en) * 2003-01-14 2005-10-26 ALTANA Pharma AG Pde4 inhibitors for the treatment of neoplasms of lymphoid cells
WO2005075457A1 (en) * 2004-02-04 2005-08-18 Altana Pharma Ag Phthalazinone-derivatives as pde4 inhibitors
DE602005005638T2 (de) 2004-02-04 2009-05-14 Nycomed Gmbh 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-on-derivate als pde4-inhibitoren
AR070454A1 (es) * 2008-02-27 2010-04-07 Nycomed Gmbh Pirrolopirimidincarboxamidas y composiciones farmaceuticas que las comprenden
AR077898A1 (es) * 2009-08-26 2011-09-28 Nycomed Gmbh Metilpirrolopirimidincarboxamidas

Also Published As

Publication number Publication date
AR086915A1 (es) 2014-01-29
CR20130656A (es) 2014-02-18
EP2721030B1 (en) 2015-12-16
TN2013000439A1 (en) 2015-03-30
CO6852074A2 (es) 2014-01-30
JP5980318B2 (ja) 2016-08-31
CA2837248A1 (en) 2012-12-20
JP2014517021A (ja) 2014-07-17
CN103582644B (zh) 2016-07-20
MX2013014888A (es) 2014-02-27
CN103582644A (zh) 2014-02-12
KR20140037195A (ko) 2014-03-26
WO2012171900A1 (en) 2012-12-20
US20140112945A1 (en) 2014-04-24
EA201400001A1 (ru) 2014-05-30
ECSP13013076A (es) 2014-01-31
US20160108049A1 (en) 2016-04-21
MA35269B1 (fr) 2014-07-03
CL2013003556A1 (es) 2014-06-13
ES2564882T3 (es) 2016-03-29
PH12013502546A1 (en) 2014-01-27
AU2012269133A1 (en) 2014-01-30
EA023713B1 (ru) 2016-07-29
EP2721030A1 (en) 2014-04-23
PE20140648A1 (es) 2014-05-30
DOP2013000298A (es) 2014-03-31

Similar Documents

Publication Publication Date Title
BR112012033350A2 (pt) "composição e métodos para modular a via de sinalização de wnt"
UA114611C2 (uk) Пестицидні композиції і способи, що їх стосуються
CU20090017A7 (es) Peptidomimeticos de smac utiles como inhibidores de proteinas de apoptosis (iap)
CR20130470A (es) INHIBIDORES DE QUINASA RELACIONADOS CON PIRROLO [2,3-d]PIRIMIDINA TROMPOMIOSINA
PE20151781A1 (es) Piridonamidas como moduladores de canales de sodio
BR112013025732A2 (pt) composto de imidazo-oxazina ou sal do mesmo
ECSP10010271A (es) Derivados de tiazol usados como inhibidores de pi 3-cinasa
ATE542813T1 (de) 6-substituierte 2- heterocyclylaminopyrazinverbindungen als chk-1- inhibitoren
SV2010003472A (es) Compuestos de pirazol
BR112013031405A2 (pt) piridopirazinas substituídas como novos inibidores de syk
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
EA201290800A1 (ru) Гетероциклическое соединение
BR112012026004A2 (pt) derivados de ariletinila
IN2014CN04530A (https=)
EA201291217A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ПРОИЗВОДНЫЕ 1-(β-D-ГЛЮКОПИРАНОЗИЛ)-2-ТИЕНИЛМЕТИЛБЕНЗОЛА КАК ИНГИБИТОРЫ НЗПГ
CR20130419A (es) Derivados heterocíclicos de amina
BR112012031340A2 (pt) derivados de cianoquinolina
BR112014028991A2 (pt) triazóis como inibidores de kv3
MX2013012211A (es) Derivados biciclicos substituidos de metil amina como moduladores de receptores de esfingosina-1-fosfato.
BR112015012825A2 (pt) piridopirazinas substituídas como inibidores de syk
BR112015023829A2 (pt) composto de amidina e seu uso
BR112014026198A2 (pt) compostos pirazol como inibidores de sglt1
BR112013031791A2 (pt) derivados de ftalazinona-pirrolopirimidinacarboxamida
BR112013027395A2 (pt) inibidores de 17alfa-hidroxilase/c17,20-liase
BR112014019220A8 (pt) Novos derivados de pirrolidina

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: NYCOMED ASSET MANAGEMENT GMBH (DE)

B25A Requested transfer of rights approved

Owner name: NYCOMED GERMANY HOLDING GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: ASTRAZENECA AB (SE)

B25A Requested transfer of rights approved

Owner name: ASTRAZENECA AB (SE)

B25L Entry of change of name and/or headquarter and transfer of application, patent and certificate of addition of invention: publication cancelled

Owner name: ASTRAZENECA AB (SE)

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2518 DE 09-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.